Last year, the national health and Family Planning Commission issued the influenza diagnosis and treatment plan (2018 version) (hereinafter referred to as the plan). The first batch of traditional Chinese medicine combined with influenza treatment plan should be updated after seven years. Among them, Yinhuang preparation has the functions of clearing away heat and toxin, anti inflammation and anti infection.
Yinhuang Chinese patent medicine has obvious advantages in treating common cold
Wang Yuguang, director of Beijing influenza hospital, pointed out that this is the principle of syndrome differentiation. When the patient has both cold and heat symptoms, it is necessary to use Chinese patent medicine to clear the lung and vent heat, so that the accumulated fire poison in the body can be discharged from the stool, so as to improve the symptoms such as fever or high fever, cough, sputum viscosity, throat pain, etc.
Experts also stressed that "abuse of antibiotics, infusion" is a common mistake in the treatment of influenza. In fact, influenza and most common colds are caused by virus infection. Antibiotics and infusion can only treat bacterial infection, which is not beneficial to the condition of a cold.
In terms of improving the symptoms of influenza, Chinese patent medicine has more advantages than western medicine. Experts pointed out that compared with chemical drugs, Chinese patent medicine has the characteristics of multi-component, multi-target, multi efficacy, less toxic and side effects, and has the function of prevention and health care, so it has exclusive advantages in the treatment of cold. Because of the active ingredients in drugs, Yinhuang products have the characteristics of mild effect, less side effects and significant therapeutic effect.
Yinhuang pill is extracted from Flos Lonicerae and Scutellaria baicalensis. The combination of the two herbs has significant effect on wind heat type cold, rapid relief of clinical symptoms, safety and reliability, and has strong broad-spectrum antibacterial and antiviral effect. Especially in the early stage of cold, adhere to take 2-4 days, cold symptoms can be alleviated, the first dose doubled, the curative effect is more obvious.

In this regard, TCM clinical experts also pointed out that the drugs recommended by the health and Family Planning Commission have been tested by the market and the curative effect is generally recognized as reliable.
Yinhuang pill was included in the recommended Chinese patent medicine of influenza diagnosis and treatment plan (2018 Edition) of health and Family Planning Commission, and was included in Guangdong hand foot mouth disease diagnosis and treatment guide (2018 Edition)
At present, there are hundreds of batch numbers of Yinhuang preparation. Yinhuang pill is the only "concentrated pill" among all Yinhuang preparations. It has less total dosage, faster disintegration, direct drinking water swallowing, higher medication compliance, sugar free and convenient for diabetics.
Yinhuang pill has a "very unique national quality standard". The content of chlorogenic acid is more than 15mg, which is more than ten times of tablets, granules and capsules. The content of baicalin is also two or three times higher than other dosage forms. Yinhuang pill is also an "exclusive", "medical insurance" and "patent" product. Chlorogenic acid is known as "the king of anti-inflammatory". It is generally believed that the anti-inflammatory effect of chlorogenic acid combined with baicalin is much better than that of Radix Isatidis and dandelion.

In this regard, industry analysts believe that Chinese patent medicines play an increasingly important role in the market of cold medicines. The reason is that compared with chemical medicines, Chinese patent medicines have slow onset, but less toxic and side effects, and are relatively safer. After the SARS incident in 2003 and the influenza A (H1N1) incident in 2009, Chinese patent medicines have shown their unique anti-virus efficacy, which has deepened people's understanding of Chinese patent medicines; From the PPA incident in 2000, the notice on Further Strengthening the management of compound preparations containing ephedrine issued by the State Food and Drug Administration in 2008, and the death of five children under two years old taking cold drugs in the UK in 2009, chemical cold drugs have been pushed to the top of the air.

Yinhuang pill, initially put into the market has been recognized by the majority of patients. This is mainly due to the consistent and strict quality standard control of shengbokang pharmaceutical. According to the authoritative finished product test report, the national standard requires that the content of chlorogenic acid in every 1g of the product should not be less than 15mg, and the internal control standard of shengbokang Yinhuang pill is 21.9 mg; the national standard should contain baicalin in every 1g of the product should not be less than 85 mg, and the content of Baicalin in shengbokang internal control standard is 114 mg. The data showed that chlorogenic acid and Baicalin in shengbokang Yinhuang pills were 46% and 34% higher than the national standard respectively, which made the clinical effect of Yinhuang pills better than many similar products. And this is the core competitiveness of Yinhuang pill, which has been recognized by consumers since its initial listing.